Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma

MLA

Shengkui Tan, et al. “Prognostic Significance and Immune Characteristics of CMTM4 in Hepatocellular Carcinoma.” BMC Cancer, vol. 22, no. 1, Aug. 2022, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12885-022-09999-y.

APA

Shengkui Tan, Xuefeng Guo, Chunhua Bei, Huixia Zhang, Di Li, Xiaonian Zhu, & Hongzhuan Tan. (2022). Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma. BMC Cancer, 22(1), 1–17. https://doi.org/10.1186/s12885-022-09999-y

Chicago

Shengkui Tan, Xuefeng Guo, Chunhua Bei, Huixia Zhang, Di Li, Xiaonian Zhu, and Hongzhuan Tan. 2022. “Prognostic Significance and Immune Characteristics of CMTM4 in Hepatocellular Carcinoma.” BMC Cancer 22 (1): 1–17. doi:10.1186/s12885-022-09999-y.